Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2011 2
2012 3
2013 3
2014 3
2015 1
2016 3
2019 2
2020 3
2021 3
2022 2
2023 6
2024 11
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1.
Besse B, Felip E, Garcia Campelo R, Cobo M, Mascaux C, Madroszyk A, Cappuzzo F, Hilgers W, Romano G, Denis F, Viteri S, Debieuvre D, Galetta D, Baldini E, Razaq M, Robinet G, Maio M, Delmonte A, Roch B, Masson P, Schuette W, Zer A, Remon J, Costantini D, Vasseur B, Dziadziuszko R, Giaccone G; ATALANTE-1 study group. Besse B, et al. Ann Oncol. 2023 Oct;34(10):920-933. doi: 10.1016/j.annonc.2023.07.006. Epub 2023 Sep 11. Ann Oncol. 2023. PMID: 37704166 Free article. Clinical Trial.
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial.
Guigay J, Aupérin A, Fayette J, Saada-Bouzid E, Lafond C, Taberna M, Geoffrois L, Martin L, Capitain O, Cupissol D, Castanie H, Vansteene D, Schafhausen P, Johnson A, Even C, Sire C, Duplomb S, Evrard C, Delord JP, Laguerre B, Zanetta S, Chevassus-Clément C, Fraslin A, Louat F, Sinigaglia L, Keilholz U, Bourhis J, Mesia R; GORTEC; AIO; TTCC, and UniCancer Head and Neck groups. Guigay J, et al. Lancet Oncol. 2021 Apr;22(4):463-475. doi: 10.1016/S1470-2045(20)30755-5. Epub 2021 Mar 5. Lancet Oncol. 2021. PMID: 33684370 Clinical Trial.
[Sinonasal cancers].
Ferrand FR, Thariat J, Verillaud B, Le Clerc N. Ferrand FR, et al. Rev Prat. 2022 Jan;72(1):71-77. Rev Prat. 2022. PMID: 35258260 French.
[Ear tumors: Surgical aspects].
Maquet C, Claudot H, Tendron A, Ferrand FR, Blanc B, Crampon F, Deneuve S. Maquet C, et al. Among authors: ferrand fr. Bull Cancer. 2025 Oct;112(10):1150-1161. doi: 10.1016/j.bulcan.2025.03.013. Epub 2025 Jun 10. Bull Cancer. 2025. PMID: 40500619 Free article. Review. French.
[Disseminated intravascular coagulation in solid tumours].
Ferrand FR, Garcia-Hejl C, Moussaid Y, Schernberg A, Bidard FC, Pavic M, Khenifer S, Stoclin A. Ferrand FR, et al. Bull Cancer. 2014 Jun;101(6):580-92. doi: 10.1684/bdc.2014.1959. Bull Cancer. 2014. PMID: 24977447 Review. French.
Beneath HMGA2 alterations in pleomorphic adenomas: Pathological, immunohistochemical, and molecular insights.
Alsugair Z, Lépine C, Descotes F, Lanic MD, Pissaloux D, Tirode F, Lopez J, Céruse P, Philouze P, Fieux M, Wassef M, Baglin AC, Mihaela O, Castain C, Sudaka A, Uro-Coste E, Champagnac A, Costes-Martineau V, Laé M, Benzerdjeb N; REFCOR network*. Alsugair Z, et al. Hum Pathol. 2024 Oct;152:105633. doi: 10.1016/j.humpath.2024.105633. Epub 2024 Jul 30. Hum Pathol. 2024. PMID: 39089476 Free article.
Survival Without Quality of Life Deterioration in the GORTEC 2014-04 "OMET" Randomized Phase 2 Trial in Patients with Head and Neck Cancer with Oligometastases using Stereotactic Ablative Radiation Therapy (SABR) alone or Chemotherapy and SABR.
Thariat J, Bosset M, Falcoz A, Vernerey D, Pointreau Y, Racadot S, Faivre JC, Castelli J, Guihard S, Huguet F, Chapet S, Tao Y, Borel C, Fayette J, Rambeau A, Ferrand FR, Pechery A, Bourhis J, Sun XS; GORTEC, 4bis rue Emile Zola, Tours. Thariat J, et al. Among authors: ferrand fr. Int J Radiat Oncol Biol Phys. 2025 Apr 1;121(5):1194-1206. doi: 10.1016/j.ijrobp.2024.11.084. Epub 2024 Nov 28. Int J Radiat Oncol Biol Phys. 2025. PMID: 39612953 Free article. Clinical Trial.
In Regard to Thariat et al.
Thariat J, Falcoz A, Ferrand FR, Bourhis J, Sun XS. Thariat J, et al. Among authors: ferrand fr. Int J Radiat Oncol Biol Phys. 2025 Jul 15;122(4):1073-1075. doi: 10.1016/j.ijrobp.2025.03.083. Int J Radiat Oncol Biol Phys. 2025. PMID: 40571359 No abstract available.
48 results